Rentschler opens GMP fill/finish facility in Austria

By Staff Reporter

- Last updated on GMT

(Image: Getty/PeterHermesFurian)
(Image: Getty/PeterHermesFurian)

Related tags: Austria, CDMO

Aseptic fill/finish contractor Rentschler Fill Solutions inaugurated the new facility in Austria’s eastern town of Rankweil.

Rentschler Fill Solutions GmbH opened the plant for the aseptic filling and freeze-drying of drug products intended for the European market.

The contract development and manufacturing organisation (CDMO) broke ground in Rankweil, Austria, in 2016. It received good manufacturing practice (GMP) certification and a European pharmaceutical manufacturing license from Austrian regulators in August 2018.

The company expects to receive US Food and Drug Administration (FDA) approval for the site in 2019.

“Together, we have successfully created an operational pharmaceutical business from scratch in record time,” ​said managing director, Reinhold Elsaesser, at the inauguration last week.

“We are now ready to help our clients bring unique active pharmaceutical ingredients to a global market. Very few companies in our region have this capability,” ​he added.

Rentschler Fill Solutions employs 59 employees and expects to increase headcount to 100 within the next two years.

In May of this year, the CDMO announced a service agreement​ with US-based Ultragenyx Pharmaceutical for commercial production.

According to the deal, Ultragenyx transferred fill/finish activities for injectable recombinant protein, Mepsevii (vestronidase alfa), from Rentschler Biopharma’s facility in Germany, to Rentschler Fill Solutions in Austria. The separate Rentschler companies are both owned by the Rentschler family.

Related news

Show more

Related products

show more

Fill-Finish Biologics

Fill-Finish Biologics

Curia | 16-May-2022 | Technical / White Paper

The clinical value of biologics for the treatment of many disease indications has been accompanied by phenomenal sales. By 2026, the global market for...

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Related suppliers